, Tracking Stock Market Picks
Enter Symbol:
Rating: CA
Buy $29

Ca Inc. (NASDAQ: CA) upgraded to Buy with price target $29 by Mizuho

Friday,  Jan 22, 2016  8:25 AM ET by Lynn Gilbert

Mizuho upgraded Ca Inc. (NASDAQ: CA) to Buy with price target $29.
Previously, Mizuho rated Ca Inc. (NASDAQ: CA) to Neutral with price target $30 on 01/16/2014, when the stock price was valued at $34.05.

Careside has developed and plans to sell a proprietary blood testing systemcalled the Careside system. It is designed to decentralize laboratoryoperations. The system consists of a testing instrument called the CareSideAnalyzer and disposable test cartridges. It performs blood tests in the same location as the patient, or what is commonly called point-of-care testing. The company's goal is to make decentralized testing with the Careside system the standard for routine and critical care blood testing.


RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy